FibroGen, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals, Inc. |
$33.31 | $2.70 B | -7.55 | 383 | $26.82 M |
AKRO
Akero Therapeutics, Inc. |
$21.86 | $1.59 B | -7.1 | 60 | $0 |
ARDX
Ardelyx, Inc. |
$5.61 | $1.51 B | -23.04 | 267 | $124.46 M |
AVRO
AVROBIO, Inc. |
$1.40 | $68.24 M | 2.2 | 13 | $0 |
BMEA
Biomea Fusion, Inc. |
$4.15 | $148.81 M | -1.17 | 107 | $0 |
BMRN
BioMarin Pharmaceutical Inc. |
$63.81 | $15.32 B | 76.12 | 3401 | $2.42 B |
BPMC
Blueprint Medicines Corporation |
$102.54 | $6.47 B | -21.48 | 638 | $249.38 M |
CGEM
Cullinan Oncology, Inc. |
$10.01 | $1.29 B | -7.16 | 85 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$11.15 | $1.12 B | -5.11 | 174 | $0 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.55 | $243.38 M | -1.59 | 133 | $0 |
GOSS
Gossamer Bio, Inc. |
$0.86 | $124.06 M | -0.65 | 135 | $0 |
HEPA
Hepion Pharmaceuticals, Inc. |
$0.48 | $6.02 M | -0.12 | 22 | $0 |
LRMR
Larimar Therapeutics, Inc. |
$3.29 | $611.84 M | -9.99 | 42 | $0 |
LYEL
Lyell Immunopharma, Inc. |
$0.58 | $619.50 M | -2.7 | 224 | $130,000 |
MREO
Mereo BioPharma Group plc |
$3.07 | $479.72 M | -22.8 | 33 | $10.00 M |
MRUS
Merus N.V. |
$39.00 | $3.50 B | -19.38 | 172 | $43.95 M |
PCVX
Vaxcyte, Inc. |
$78.16 | $7.72 B | -16.54 | 254 | $0 |
RVMD
Revolution Medicines, Inc. |
$39.79 | $6.66 B | -10.51 | 490 | $11.58 M |
SNDX
Syndax Pharmaceuticals, Inc. |
$12.60 | $1.66 B | -6.02 | 184 | $0 |
STOK
Stoke Therapeutics, Inc. |
$8.66 | $774.50 M | -6.14 | 110 | $8.78 M |
STRO
Sutro Biopharma, Inc. |
$1.72 | $303.46 M | -1.97 | 302 | $153.73 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
VSTM
Verastem, Inc. |
$5.04 | $86.11 M | -0.79 | 73 | $0 |
ZURA
Zura Bio Limited |
$1.95 | $255.37 M | 6.17 | 14 | $0 |